# Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 100mg

> **NCT02485041** · PHASE1 · COMPLETED · sponsor: **SK Chemicals Co., Ltd.** · enrollment: 36 (actual)

## Conditions studied

- Drug Interaction Potentiation

## Interventions

- **DRUG:** Dapoxetine 30mg
- **DRUG:** Mirodenafil 100mg

## Key facts

- **NCT ID:** NCT02485041
- **Lead sponsor:** SK Chemicals Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2015-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02485041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02485041, "Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 100mg". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02485041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*